Spiroglumide
CAS No. 137795-35-8
Spiroglumide( —— )
Catalog No. M36133 CAS No. 137795-35-8
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 240 | Get Quote |
|
| 5MG | 371 | Get Quote |
|
| 10MG | 561 | Get Quote |
|
| 25MG | 868 | Get Quote |
|
| 50MG | 1178 | Get Quote |
|
| 100MG | 1557 | Get Quote |
|
| 500MG | 3114 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSpiroglumide
-
NoteResearch use only, not for human use.
-
Brief DescriptionSpiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
-
DescriptionSpiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCholecystokinin Receptor
-
Recptorcholecystokinin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number137795-35-8
-
Formula Weight441.35
-
Molecular FormulaC21H26Cl2N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@H](NC(=O)C1=CC(Cl)=CC(Cl)=C1)CCC(O)=O)(=O)N2CCC3(CC2)CCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Lintitript
Lintitript is a selective antagonist of CCK1 with EC50s of 6 nM and 200 nM for CCK1 and CCK2. The Ki value is 0.2 nM for CCK1.
-
WAY-620645
WAY-620645 is a CCK antagonist with antitumor and analgesic activities.
-
JNJ-26070109
A novel, potent, selective orally active CCK-2 receptor antagonist with pKi of 8.49 for hCCK2.
Cart
sales@molnova.com